Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob Scott

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Research Square|May 2, 2025
Multifactorial stroma-mediated resistance is a major contributor to residual disease under targeted therapies in lung cancersBina Desai, Tatiana Miti, Sandhya Prabhakaran, et al.
Nature Communications|May 16, 2020
Resistance to targeted therapies as a multifactorial, gradual adaptation to inhibitor specific selective pressuresRobert Vander Velde, Nara Yoon, Viktoriya Marusyk, et al.
Immunotherapy|April 20, 2012
Serial assessment of lymphocytes and apoptosis in the prostate during coordinated intraprostatic dendritic cell injection and radiotherapySteven Eric Finkelstein, Francisco Rodriguez, Mary Dunn, et al.
Iscience|March 17, 2023
A multimodal analysis of genomic and RNA splicing features in myeloid malignanciesArda Durmaz, Carmelo Gurnari, Courtney E Hershberger, et al.
Neuro-Oncology|May 17, 2014
Invasion and proliferation kinetics in enhancing gliomas predict IDH1 mutation statusAnne L Baldock, Kevin Yagle, Donald E Born, et al.
Nature Communications|May 29, 2026
Multifactorial sheltering in peristromal niches shapes in vivo responses of lung cancers to targeted therapiesBina Desai, Tatiana Miti, Sandhya Prabhakaran, et al.
Blood|June 2, 2021
Machine learning integrates genomic signatures for subclassification beyond primary and secondary acute myeloid leukemiaHassan Awada, Arda Durmaz, Carmelo Gurnari, et al.
Nature Communications|May 30, 2023
Molecular patterns identify distinct subclasses of myeloid neoplasiaTariq Kewan, Arda Durmaz, Waled Bahaj, et al.
Nature Communications|February 8, 2024
Author Correction: Molecular patterns identify distinct subclasses of myeloid neoplasiaTariq Kewan, Arda Durmaz, Waled Bahaj, et al.
Msphere|July 9, 2024
A summary of the main themes and findings presented at the ASM Intermountain Branch meeting (2024)Jay Radke, Javier Ochoa-Repåraz, Jamee Nixon, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Research Square|May 2, 2025
Multifactorial stroma-mediated resistance is a major contributor to residual disease under targeted therapies in lung cancersBina Desai, Tatiana Miti, Sandhya Prabhakaran, et al.
Nature Communications|May 16, 2020
Resistance to targeted therapies as a multifactorial, gradual adaptation to inhibitor specific selective pressuresRobert Vander Velde, Nara Yoon, Viktoriya Marusyk, et al.
Immunotherapy|April 20, 2012
Serial assessment of lymphocytes and apoptosis in the prostate during coordinated intraprostatic dendritic cell injection and radiotherapySteven Eric Finkelstein, Francisco Rodriguez, Mary Dunn, et al.
Iscience|March 17, 2023
A multimodal analysis of genomic and RNA splicing features in myeloid malignanciesArda Durmaz, Carmelo Gurnari, Courtney E Hershberger, et al.
Neuro-Oncology|May 17, 2014
Invasion and proliferation kinetics in enhancing gliomas predict IDH1 mutation statusAnne L Baldock, Kevin Yagle, Donald E Born, et al.
Nature Communications|May 29, 2026
Multifactorial sheltering in peristromal niches shapes in vivo responses of lung cancers to targeted therapiesBina Desai, Tatiana Miti, Sandhya Prabhakaran, et al.
Blood|June 2, 2021
Machine learning integrates genomic signatures for subclassification beyond primary and secondary acute myeloid leukemiaHassan Awada, Arda Durmaz, Carmelo Gurnari, et al.
Nature Communications|May 30, 2023
Molecular patterns identify distinct subclasses of myeloid neoplasiaTariq Kewan, Arda Durmaz, Waled Bahaj, et al.
Nature Communications|February 8, 2024
Author Correction: Molecular patterns identify distinct subclasses of myeloid neoplasiaTariq Kewan, Arda Durmaz, Waled Bahaj, et al.
Msphere|July 9, 2024
A summary of the main themes and findings presented at the ASM Intermountain Branch meeting (2024)Jay Radke, Javier Ochoa-Repåraz, Jamee Nixon, et al.
Pageof 6